LIVE DEMO | MAY 8, 2025 | 10 am PT / 1 pm ET
Experience Unmatched Visibility into Site Activation
Advarra’s study startup software and eIRB system are now integrated!
Join us for a live, 30-minute demo on May 8th at 10 am PT / 1 pm ET.
Guide your sites through the activation process and automatically track how they progress through each milestone.
To get sites ready to enroll, study teams need up-to-date visibility into critical milestones, with flexibility to adapt processes for each unique site. Advarra Study Startup’s configurable, yet guided approach to activation keeps teams like yours on-track and progressing through each critical path towards enrollment.
Join us Thursday, May 8 for a 30-minute live demonstration of Advarra Study Startup’s latest release: seamless integration with Advarra’s eIRB software (CIRBI).
Join us to learn how to:
- View Progress: Gain immediate visibility into activation progress across every study and every site
- Track Approval Status: Track IRB approval status across all your North American sites without ever leaving the study startup system
- Seamlessly Collaborate: Collaborate with over 14,000 sites in the system they’re already using to submit feasibility surveys, exchange essential documents, and master study training
Get a sneak peek:
Meet the Expert Speakers
Mike Ekrote
SVP Strategic Solutions, Advarra
Ashley Davidson
VP Product Lead, Sponsor Tech, Advarra
Jay Knudson
Solutions Consultant, Advarra
Register to Join us Live
Connecting more than 14,000 sites and 225,000 users, across 89 countries and counting.
Why Research Leaders Trust Advarra
Advarra’s technology has played an important role in consolidating multiple site tasks into one streamlined integrated system — including study training, document exchange, communication, and visit guidance — providing sites access via ‘Advarra One’ single sign on, which has been widely adopted by the clinical research community.
Deb Tatton, President, Global Clinical and Data Operations, Parexel
The interoperability of Advarra’s technologies simplifies our study startup workflows, which is especially important for industry trials that require a lot of coordination with sponsors and CROs. By removing redundancies in study startup activities, we save time and shorten our activation timelines.
Denise Snyder, Associate Dean of Clinical Research, Duke University School of Medicine
We are continuously improving the study startup process to reduce the administrative burden for sites and give sponsors better visibility into trial timeline.
Mark Morais, President and COO of Clinical Development at Fortrea
Start Clinical Trial Enrollment Sooner
